FH
protein-codingfumarate hydratase
Gene summary
The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~22.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005058
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0017366
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011730
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011730
Submitter: Natera
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011730
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011730
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011730
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: ClinGen
Heterozygous variants in the fumarate hydratase (FH) gene are associated with the autosomal dominant disorder hereditary leiomyomatosis and renal cell cancer (HLRCC). This was first proposed by Tomlinson et al in 2002 (PMID: 11865300). Numerous genetic studies have reported familial segregation of FH variants in families with leiomyomatosis or renal cell cancer. Affected individuals with heterozygous mutations had decreased fumarate hydratase enzyme activity in their lymphoblastoid cell lines although penetrance varies among individuals with similar decreases in FH activity. Tumors from HLRCC patients with a FH germline heterozygous mutations presented markedly reduced enzyme activity due to a second hit on FH, compared with tumors with similar histology from non HLRCC patients. There are substantial other functional assays demonstrating deficiency of FH activity and abnormality in smooth muscle differentiation. In summary, FH is definitively associated with HLRCC. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0035540
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011730
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007888
Submitter: Natera
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Dermatologic; Neurologic; Obstetric; Oncologic
Intervention: Obstetric; Oncologic
Rationale: Regular surveillance for dermatologic and uterine neoplasms can be beneficial in order to allow early detection and treatment (which can include medical management and/or surgical excision); Surveillance for renal neoplasms can allow early detection and treatment, which may include total nephrectomy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000143.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 481 | 24 | 511 | |
| missense | 21 | 231 | 982 | 42 | 1 | 1277 |
| nonsense | 50 | 22 | 1 | 73 | ||
| start loss | 8 | 8 | ||||
| frameshift | 168 | 32 | 5 | 205 | ||
| splice donor/acceptor (+/-2bp) | 25 | 53 | 6 | 84 | ||
| Total | 264 | 347 | 999 | 523 | 25 | 2158 |
Highest pathogenic variant AF is 0.0019145409
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000134.2 | 10 | MANE Select | |
| Ensembl | ENSP00000355518.4 | 10 | MANE Select | |
| Ensembl | ENSP00000508203.1 | 3 | Standard | |
| Ensembl | ENSP00000506864.1 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| fh | Danio rerio | Structure: whole organism Quality: dead abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Citrate cycle (TCA cycle) - Homo sapiens (human)
- Pyruvate metabolism - Homo sapiens (human)
- Renal cell carcinoma - Homo sapiens (human)
- Cushing,s syndrome - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
Biological Process
- tricarboxylic acid cycle
- fumarate metabolic process
- malate metabolic process
- homeostasis of number of cells within a tissue
- positive regulation of cold-induced thermogenesis
Molecular Function
- fumarate hydratase activity
- protein binding
Cellular Component
- cytoplasm
- mitochondrion
- mitochondrial matrix
- tricarboxylic acid cycle enzyme complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000366560
- Coding exons
- 10
- Length
- 22159
- Individuals with no LoFs
- 125736
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 11
- Defined
- 125747
- p
- 0.0000437
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.27 | 223 | 283 | 0.787 | 0.0000143 | 3330 |
| Missense (PolyPhen) | 73 | 118.15 | 0.61785 | 1402 | ||
| Synonymous | -0.323 | 105 | 101 | 1.04 | 0.00000533 | 1025 |
| Loss of Function | 3.13 | 6 | 21.8 | 0.276 | 0.00000108 | 270 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Also acts as a tumor suppressor.;
- Disease
- DISEASE: Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800]: A disorder characterized by predisposition to cutaneous and uterine leiomyomas, and papillary type 2 renal cancer which occurs in about 20% of patients. {ECO:0000269|PubMed:11865300}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.630
Intolerance Scores
- LoFtool
- 0.0747
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.25
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.976
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |